Completed PHASE4 INTERVENTIONAL NCT00477737

Early Cardioprotective Effect of Sevoflurane

Early Cardioprotective Effect of Sevoflurane on Left Ventricular Performance During Coronary Artery Bypass Grafting on a Beating Heart

Sponsor: University Hospital Dubrava

Conditions Coronary Artery Disease Off Pump Coronary Artery Bypass Surgery

Interventions Sevoflurane propofol

Updated 5 times since 2017 Last updated: May 23, 2007 Started: Aug 31, 2006 Completion: Dec 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00477737, this PHASE4 trial focuses on Coronary Artery Disease and Off Pump Coronary Artery Bypass Surgery and remains completed. Sponsored by University Hospital Dubrava, it has been updated 5 times since 2006, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Aug 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital Dubrava

Data source: University Hospital Dubrava

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zagreb, Croatia